Literature DB >> 26146860

Immunity, Inflammation, and Prehypertension: In What Order?

Arthur Sá Ferreira1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26146860      PMCID： PMC8031551          DOI： 10.1111/jch.12611

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  10 in total

1.  Integrative medicine for hypertension: the earlier the better for treating who and what are not yet ill.

Authors:  Arthur de Sá Ferreira
Journal:  Hypertens Res       Date:  2013-04-11       Impact factor: 3.872

Review 2.  Inflammation and hypertension: new understandings and potential therapeutic targets.

Authors:  Carmen De Miguel; Nathan P Rudemiller; Justine M Abais; David L Mattson
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 3.  Inflammation, immunity, and hypertension.

Authors:  David G Harrison; Tomasz J Guzik; Heinrich E Lob; Meena S Madhur; Paul J Marvar; Salim R Thabet; Antony Vinh; Cornelia M Weyand
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

Review 4.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

5.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

6.  Elevated Serum Level of Interleukin 17 in a Population With Prehypertension.

Authors:  Wei Yao; Yuemin Sun; Xuechun Wang; Kaijun Niu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-03       Impact factor: 3.738

Review 7.  The natural history of hypertension: prehypertension or masked hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

8.  Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension.

Authors:  Alexandre Bastos Luiz; Arthur Sá Ferreira; Ivan Cordovil; José Barbosa Filho
Journal:  Chin Med       Date:  2011-06-17       Impact factor: 5.455

9.  Statistical problems in epidemiologic studies of the natural history of disease.

Authors:  R Brookmeyer
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

Review 10.  Hypertension in children and adolescents: epidemiology and natural history.

Authors:  Bonita Falkner
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714
  10 in total
  2 in total

1.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

2.  Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Authors:  Silvio Antoniak; Jessica C Cardenas; Laura J Buczek; Frank C Church; Nigel Mackman; Rafal Pawlinski
Journal:  Cardiology       Date:  2016-11-24       Impact factor: 1.869
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.